Congress on Thrombosis
Ljubljana, Slovenia, June 20-24, 2004
International Congresses on Thrombosis organized under the auspices of
the Mediterranean League against Thromboembolic Diseases every two years,
have developed their own continuity and tradition along the following
lines: they are established and recognized as main scientific events
occurring in the “even” years in the field of thrombosis based diseases
and blood coagulation disorders; although usually organized in a country
of the Mediterranean area, participation and audience is representative
of Europe at large, of both Americas, and other overseas countries; they
are characterized by a predominant clinical interest focusing on
epidemiology, diagnosis, therapy, management and prevention of
thromboembolic diseases, not neglecting basic research in thrombosis and
haemostasis; due to this clinical imprint, they are largely
multidisciplinary and attract virtually all medical specialists
including haematologists, internists, cardiologists, neurologists,
surgeons, critical care doctors besides blood coagulation and thrombosis
The 18th International Congress on Thrombosis was held in Ljubljana,
Slovenia, from June 20 to June 24, 2004. Traditionally, invited plenary
and state-of-the-art lectures and lectures in symposia are published in
the League’s official joural Pathophysiology of Haemostasis and
Thrombosis. Other authors were given the opportunity to contribute, if
they decided to do so, to this publication of Medimond – Monduzzi
Editore International Proceedings Division. A number of authors has
indeed accepted this offer and a publication was produced representative
of a considerable part of the Congress.
We wish to thank all authors contribution to this publication thus
allowing a more complete documentation of the 18th International
Congress on Thrombosis and activities of the Mediterranean League
against Thromboembolic Diseases.
Prof. Mojca Stegnar
President of the 18th International Congress on Thrombosis
Prof. Polona Peternel
Doc. Matija Kozak
Dr. Mojca Bozič
Venous Thromboembolism - Clinical
Evaluation of the Symptoms of Acute Venous Thromboembolism
R.A. Rached, L. Pereira, A. De Piano, C. Cavalheiro Filho, C.M. Cassaro
W. Arminio Hueb, L.F. Cardoso, R. Del Valhe, A. Rached, D. Birolini and D.
de Alencar Fischer Chamone
Venous Thromboembolism and Spinal Surgery
K. Hitos, M. Dexter, A. Kam, G. Dandie, A. Cree, G. Butler, K. Saker and J.
Soluble Tissue Factor in Plasma from Patients with Acute Myocardial
Infarction Is Not Microvesicle- Associated
I. Seljeflot, T. Lyberg and H. Arnesen
Prothrombotic Risk in White Coat Hypertensives
G.D. Theodossiades, G.P. Vyssoulis, E.A. Karpanou, A.J. Zervoudaki, V.H.
D.V. Kokkinos and C.I. Stefanadis
Use of Low-molecular-weight Heparin in Early Cardioversion
A. Dokler Glavnik, F. Škrabl Močnik, P. Zohar, M. Bervar, M. Marinšek and R.
The Long-Term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor
Blocker (Abciximab: ReoPro®)-Coated Stent in Patients with Coronary Artery
W. Kim, M.H. Jeong, Y.J. Hong, S.Y. Lim, J.H. Kim, Y.K. Ahn, J.G. Cho, J.C.
Park, D.L. Cho, H. Kim and J.C. Kang
Plasminogen Activator Inhibitor I (PAI-I) –675 5G/4G polymorphism in
patients with Coronary Artery Disease
G. Apergis, M. Belia, A. Bratsas, E. Pavlou, S. Brili, A. Gafou, J.
Georgopoulos, C. Stefanadis and E. Andrioti
The Long-Term Clinical Outcomes of Platelet Glycoprotein IIb/IIIa Inhibitor
Combined with Low Molecular Weight Heparin in Patients with Acute Coronary
J.H. Kim, M.H. Jeong, Y.J. Hong, H.W. Park, W. Kim, Y.K. Ahn, J.G. Cho, J.C.
Park and J.C. Kang
Anticoagulation in Conventional Versus Transesophageal Echocardiography (TEE)
Guided Cardioversion (CV) of Atrial Fibrillation (AF)
A. Dokler Glavnik, P. Zohar, R. Gunzek, M. Bervar, M. Marinšek and F. Škrabl
Outpatient Tinzaparin Therapy in 102 Patients with Pulmonary Embolism –
C.-G. Olsson, U. Bitzén, M. Carlsson, K.Ĺ. Jönsson, P. Magnusson, B. Olsson,
B. Jonson and M. Bajc
D-dimer Levels in Long Term Anticoagulated Patients
A. Gafou, K. Maragos, V. Tsevrenis, E. Nomikou, M. Bellia, G. Theodosiadis,
E. Paulou and E. Andrioti
Cervical Artery Dissection: Long Term Outcome After Anticoagulant Therapy
with LMWH As Initial Treatment
R. Quintavalla, E. Paganelli,
C. Pattacini, A. Rossetti, C. Manotti and P. Piazza
Prothrombin G20210 Mutation and Association with Severe Life Threatening
Thrombosis Among Thrombophilic Patients
M. Bellia, S. Sklavou, G. Theodosiades, A. Gafou, J. Georgopoulos and E.
Perinatal and Paediatric Haemostasis
Alterations of Coagulation Pathway Parameters in Children with Acute
Lymphoblastic Leukaemia (ALL)
E.S. Hatzipantelis, M. Athanassiou-Metaxa, V. Tzimouli, D. Kleta, N.
Gombakis, V. Garipidou, F. Athanasiadou-Piperopoulou, V. Sidi-Fragandrea, H.
Tsantali, D.E. Koliouskas and F. Kanakoudi-Tsakalidou
Is Long Term Prophylaxis in Pediatric Stroke Necessary? A Single Center
Ö. Ünal, Z. Uysal, G. Öcal, N. Akar and G. Deda
Alterations of Coagulation Pathway Parameters in Children with Sickle Cell
E.S. Hatzipantelis, M. Athanassiou-Metaxa, A. Taparkou, D. Kleta, T.
Gerotziafa, N. Gombakis, I. Tsatra, A. Koussi, H. Tsantali, V. Garipidou and
Methods in Coagulation
Anti-Xa Activity Monitoring of the Synthetic Pentasaccharide Fondaparinux
P. Van Dreden, S. Fontaine and B. Woodhams
A New TAFI Antigen Assay Independent of Polymorphism 325Thr/Ile and147 Ala/Thr
H. Cost, M. Grimaux, M. Grosley and B. Woodhams
Effect of Platelet Factor 4 on Laboratory Tests for the Protein C System
P. Van Dreden, A. Rousseau and B. Woodhams
Other Aspects of Thromboembolism
Coordinated Dysregulation of Cellular Receptors, Proangiogenic Factors and
Intracellular Pathways in Acute leukemia
N. Barbarroja, Ch. Lopez-Pedrera, P. Buendía, E. Siendones, M. Capote, C.
Montiel-Duarte, G. Dorado, A. Torres and F. Velasco
Phase I Double Blind, Placebo Controlled, Ascending Single Intravenous Dose
Study with a Synthetic Direct Thrombin Inhibitor, TGN255
S. Combe, G. Allen and T. Kennedy
Regulation of NFkB Activation in Anti-Phospholipid Syndrome: Involvement of
ERK1/2 and p38 MAP Kinase Pathways
P. Buendía, Ch. López-Pedrera, N. Barbarroja, E. Siendones, C.
Montiel-Duarte, G. Dorado, M.A. Aguirre, M.J. Cuadrado, A. Torres and F.
Prolonged Increase of Plasma Vitamin K2 Concentration by Natto (Bacillus
subtilis natto) Ingestion
C. Yatagai, Y. Yanagisawa, T. Ohsugi and H. Sumi